Photo from Allison Betof Warner/X
Apr 8, 2024, 20:03
Allison Betof Warner: Our Melanoma and Cell Therapy teams at Stanford Cancer Institute performed the first commercial lifileucel infusion
Allison Betof Warner, Director of Melanoma Medical Oncology and Solid Tumor Cellular Therapy at Stanford Cancer Institute, recently posted on X/Twitter:
”Incredibly proud of our Melanoma and Cell Therapy teams at Stanford Cancer Institute. We performed the first commercial lifileucel (AMTAGVI) infusion this afternoon. We are so excited to bring this treatment for advanced melanoma to our patients!(posted with consent).”
Source: Allison Betof Warner/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14